Nita Patel
#105,214
Most Influential Person Now
Indian-American physician and vaccinologist
Nita Patel's AcademicInfluence.com Rankings
Nita Patelmedical Degrees
Medical
#3635
World Rank
#4121
Historical Rank
Public Health
#647
World Rank
#669
Historical Rank
Nita Patelphilosophy Degrees
Philosophy
#11836
World Rank
#16366
Historical Rank
Logic
#9095
World Rank
#11473
Historical Rank
Download Badge
Medical Philosophy
Nita Patel's Degrees
- Bachelors Medicine University of Mumbai
- PhD Vaccinology Stanford University
Why Is Nita Patel Influential?
(Suggest an Edit or Addition)According to Wikipedia, Nita K. Patel is an Indian-American vaccinologist who leads vaccine development at Novavax. She oversaw the development of the Novavax COVID-19 vaccine. Early life and education Patel was born in Sojitra, a farming village in Gujarat. When she was four years old her father contracted tuberculosis, and came close to death. This experience motivated Patel to become a physician and attempt to find a cure for tuberculosis. She went on to earn a master's degree in microbiology at Sardar Patel University and a master's degree in biotechnology at Johns Hopkins University.
Nita Patel's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (2020) (811)
- Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. (2007) (341)
- Increasing the Affinity of a Human IgG1 for the Neonatal Fc Receptor: Biological Consequences1 (2002) (296)
- SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice (2021) (257)
- A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-YTE, Has an Extended Half-Life in Healthy Adults (2013) (243)
- Castor oil based polyurethane adhesives for wood-to-wood bonding (2003) (201)
- NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge (2020) (187)
- Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization. (2005) (181)
- Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate (2020) (165)
- Active and Passive Immunity against Borrelia burgdorferi Decorin Binding Protein A (DbpA) Protects against Infection (1998) (154)
- Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate (2020) (152)
- A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants (2017) (147)
- DbpA, but Not OspA, Is Expressed by Borrelia burgdorferi during Spirochetemia and Is a Target for Protective Antibodies (1998) (119)
- Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein (2015) (105)
- Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and/or motavizumab. (2011) (88)
- Isolation and Characterization of Monoclonal Antibodies Which Neutralize Human Metapneumovirus In Vitro and In Vivo (2006) (87)
- SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in mice (2020) (81)
- Infection and Propagation of Human Rhinovirus C in Human Airway Epithelial Cells (2012) (78)
- Molecular investigation on strain genetic relatedness and population structure of Beauveria bassiana. (2003) (62)
- Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants. (2004) (60)
- Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination (2021) (57)
- Natural polymorphisms and resistance-associated mutations in the fusion protein of respiratory syncytial virus (RSV): effects on RSV susceptibility to palivizumab. (2012) (51)
- Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants. (2019) (50)
- GUAR GUM: A VERSATILE MATERIAL FOR PHARMACEUTICAL INDUSTRIES (2014) (41)
- Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes. (2017) (41)
- First-in-Human Trial of a SARS CoV 2 Recombinant Spike Protein Nanoparticle Vaccine (2020) (40)
- Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus (2008) (40)
- Evidence for Vaccine Synergy between Borrelia burgdorferi Decorin Binding Protein A and Outer Surface Protein A in the Mouse Model of Lyme Borreliosis (2000) (33)
- Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination (2021) (32)
- Zero-order release of aspirin, theophylline and atenolol in water from novel methylcellulose glutarate matrix tablets. (2006) (28)
- Synthesis, Characterization and Optimization of Water-Soluble Chitosan Derivatives (2009) (25)
- Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA (2020) (23)
- Conformational Nature of the Borrelia burgdorferiDecorin Binding Protein A Epitopes That Elicit Protective Antibodies (2001) (23)
- Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M–Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine (2020) (20)
- Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge. (2018) (19)
- Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial. (2021) (17)
- Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection. (2019) (16)
- Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination (2021) (12)
- Combination Respiratory Vaccine Containing Recombinant SARS-CoV-2 Spike and Quadrivalent Seasonal Influenza Hemagglutinin Nanoparticles with Matrix-M Adjuvant (2021) (12)
- Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial (2022) (11)
- Immunogenicity and Safety Following a Homologous Booster Dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): A Phase 2 Randomized Placebo-Controlled Trial (2021) (11)
- Immunogenicity and In vivo protection of a variant nanoparticle vaccine that confers broad protection against emerging SARS-CoV-2 variants (2021) (9)
- Grafting of Vinyl Monomers onto Sodium Salt of Partially Carboxymethylated Guar Gum: Comparison of Their Reactivity (2005) (8)
- Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity (2020) (8)
- BIOCONVERSION OF GLYCEROL (2014) (7)
- Controlled Release of Carbamazepine from Carboxymethyl Chitosan-Grafted- 2-Hydroxyethylmethacrylate Matrix Tablets (2010) (7)
- Synthesis and Characterization of Poly (2-Methoxycyanurate) of Bisphenol-A and Bisphenol-F (1991) (6)
- Synthesis and characterization of Sodium salt of partially carboxymethylated starch (2002) (6)
- Comparison of the Safety and Immunogenicity of a Novel Matrix-M-adjuvanted Nanoparticle Influenza Vaccine with a Quadrivalent Seasonal Influenza Vaccine in Older Adults: A Randomized Controlled Trial (2020) (5)
- Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein (2019) (5)
- Potential for Palivizumab Interference With Commercially Available Antibody–antigen Based Respiratory Syncytial Virus Diagnostic Assays (2013) (5)
- Characterization of a New Class of Polycyclic RSV Inhibitors (2007) (5)
- A novel approach to synthesize carboxymethyl guar gum via friedel craft acylation method (2014) (3)
- Biodegradable Composition Based on Low Density Polyethylene (2005) (3)
- Polyol from castor oil and epoxy resin for PU Coatings (2003) (3)
- Optimization of reaction condition for carboxylicpropyl starch from potato starch (2018) (3)
- Synthesis, Characterization and Biodegradation of Low Density Polyethylene [LDPE] and Partially Carboxymethylated Starch [PCMS] Blend (2005) (3)
- Immunogenicity of a Fourth Homologous Dose of NVX-CoV2373 (2023) (2)
- Synthesis , characterization and application of borax cross-linked carboxymethyl guar gum (2015) (2)
- Synthesis, Characterization and Optimization of Reaction Parameters for Sodium Salt of Partially Carboxymethylated Okra Gum (2017) (2)
- Optimization of reaction parameters to prepare HPMA- g -Na-PCMS using can as an initiator (2001) (2)
- Modification of Asphalt using Castor Oil Based Polyurethane (2016) (2)
- Immune Correlates of Protection from Filovirus Efficacy Studies in Non-Human Primates (2022) (2)
- Formulation and evaluation of coated floating tablets of captopril (2012) (1)
- Environmentally Degradable Blends of Low Density Polyethylene (LDPE) and Partially Carboxymethylated Starch (PCMS) (2001) (1)
- Iodine catalyzed acetylation of guar gum (2014) (1)
- Polyethylene-g-Maleic Anhydride, a Compatibility Booster in Low Density Polyethylene and Polyvinylacetate Blend Preparations (2001) (1)
- 2-HEMA-g-Na-PCMS: A Novel Polymeric Matrix for the Controlled Release of Paracetamol (2009) (1)
- Bioconversion of waste glycerol to 1 , 3-propanediol and its application (2014) (1)
- Correction for Hao et al., Infection and Propagation of Human Rhinovirus C in Human Airway Epithelial Cells (2015) (1)
- Synthesis and characterization of low density polyethylene graft maleic anhydride (LDPE-g-MA) and polyvinyl acetate (PVAc) blends (2002) (1)
- LB19. Progress Toward a Vaccine for Maternal Immunization to Prevent Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Illness (LRTI) in Infants (2018) (1)
- MOLECULAR HYBRIDIZATION TECHNIQUES AND POLYMERASE CHAIN REACTION (PCR) AS METHODS FOR SAFETY ASSESSMENT OF ANIMAL CELLS USED IN BIOPHARMACEUTICAL PRODUCTION (1992) (0)
- Optimization of Reaction Parameter to Prepare 2-HEMA-g-NaPCMS Using CAN as an Initiator (2001) (0)
- Novel biodegradable packaging materials based on recycled polyethylene waste (2013) (0)
- SYNTHESIS AND CHARACTERIZATION OF POLYOL BY BIOCONVERSION OF GLYCEROL (2015) (0)
- Synthesis and characterization of sodium salt of partially carboxymethylated guar gum (2015) (0)
- Immunoglobulin A, immunoglobulin G, and neutralizing antibodies to respiratory syncytial virus increase in human milk following immunization with an RSV F protein vaccine (2019) (0)
- NOVEL SKIN FORMULATION DERIVED FROM TOBACCO WASTE (2018) (0)
- Synthesis and characterization of polymeric hydrogels for drug preparation and its release study (2016) (0)
- Immunogenicity and safety of a 4th homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a phase 2, randomized, placebo-controlled trial (2022) (0)
- Biodegradation of 2-HEMA-g-Na-PCMS a polymeric matrix synthesized from natural modified carbohydrates (2002) (0)
- Synthesis and Characterization of Polymeric Drug Binder from Tobacco Waste (2017) (0)
- Characterization of Respiratory Syncytial Virus (RSV) Mutants Resistant to Antibody Neutralization with Novel Amino Acid Changes in the RSV Fusion Protein (2008) (0)
- NOVEL METHOD OF BIOCONVERSION OF WASTE GLYCEROL ACQUIRED DURING BIODIESEL PRODUCTION (2015) (0)
- Diet Induced Obesity and Diabetes Enhance Mortality and Reduces Vaccine Efficacy for SARS-CoV-2 (2022) (0)
- Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents: A Randomized Clinical Trial. (2023) (0)
- Synthesis and Characterization of Polymeric Hydrogels for Drug Release Formulation and Its Comparative Study (2017) (0)
- A Survey on Face Recognition System used in Criminal Detection (2018) (0)
- 2753. Induction of Broadly Cross-Reactive Immune Responses Against A(H3N2) Airuses: Results of a Phase 2 Trial of a Novel Recombinant Hemagglutinin Saponin-Adjuvanted Nanoparticle Seasonal Influenza Vaccine (2019) (0)
- LB746. Safety and Immunogenicity of a Booster Dose of Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) in Adults from the PREVENT-19 Trial in the United States (2022) (0)
- Heavy and Fine Chemicals (Chemical Process Technology) (2014) (0)
- Development of Mechanism for Frictional Stir Welding of Cylindrical Pipes (2020) (0)
- In-Vitro Release S tudy of Paracetamol Using Carboxy Methyl Guar Gum as B inder (2014) (0)
- A novel biological route for 1 , 3-propanediol synthesis through transesterification of cottonseed oil (2015) (0)
- Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants (2023) (0)
This paper list is powered by the following services:
Other Resources About Nita Patel
What Schools Are Affiliated With Nita Patel?
Nita Patel is affiliated with the following schools:
